The a b i l i to generate stable high-titer vectors that give rise to high levels of expression of transduced globin genes in erythroid d l s is a prerequisite for dfective retrovird-diated globin gene therapy. The human #%globin gene with its immediate flanking sequences does not contain all the regulatory elements necessary for regulated high-level and position-independent expression in erythroid cells. The regulatory element known as the 8-globin locus control region WLCRl can provide a linked @globin gene with those properties. However, addition of 8LCR sequences to a retrovirus camying a &globin gene increases its genetic instability. We have developed a new generation of retroviral vectors in which a human yglobin gene is placed under the c o n t r o l of the aLCR, the major regulatory element ofthe a-globin gene ICKLE CELL DISEASE and 8-thalassemia are singlegene disorders that are potentially curable by gene therapy. The former is a result of a mutation that alters the structure of &globin chains, whereas the latter results from one of many mutations that decrease @-globin production. The molecular bases of these disorders have been thoroughly characterized, and the major regulatory elements of the p- 
The publication costs of this article were &frayed in part by page charge payment. This article must therefore be hereby marked "advertisemnt" in accordnnce with 18 U.S.C. seclion 1734 solely to indicate this fact. globin gene cluster known as the PLCR @-globin locus control region) promised to facilitate globin gene therapy by increasing the level of expression of transduced genes in erythroid cells. Several studies have shown that retroviruses carrying some or all of the hypersensitive sites that make up the PLCR can give rise to high levels of expression of the human &globin gene in transduced cells?-7 However, these BLCR sequence elements appear highly recombinogenic and result in a dramatic increase in genetic instability of the retroviral constructs. This instability is associated with lowtiter retroviral stocks that infect hematopoietic stem ceils at a low effi~iency.'.~
We have recently shown that a 255-bp core of the major regulatory element of the a-globin gene cluster known as HS-40: or aLCR, is capable of enhancing the activity of a heterologous promoter such as the viral W 4 0 promoter in an erythroid-specific manner? In the course of these studies, we observed that aLCR sequences are less recombinogenic in bacteria than @LCR sequences ( S . Ren and G.F. Atweh, unpublished observations, August 1992). Based on these observations, we hypothesized that the aLCR core element may be capable of activating a 0-like globin gene in retroviral vectors. We also hypothesized that the improved genetic stability of such retroviruses may allow their production at higher titers. In this report, we describe the production of high-titer stocks of retroviral vectors that carry the human *y-globin gene under the control of the aLCR. We demonstrate that these retroviral vectors are genetically stable when they integrate in the genome of NIH 3T3 cells and MEL cells. More importantly, human y-globin genes that are transduced by these retroviruses are expressed at high levels in MEL cells. We also show that these novel gene transfer vectors can infect primary murine bone marrow colonyforming units ( C m ) as efficiently as the parental retroviral vectors that carry the neo' marker gene alone. It remains to be seen whether the lack of copy-number dependence that was observed in transgenic mice" is relevant to the utility of this generation of retroviral vectors for the gene therapy of hemoglobin disorders. . . globin gene transfer construct described in this report. This vector contains a selectable neo' gene flanked by two long terminal repeats (LTRs) from the Moloney murine leukemia virus.'' The human *yglobin gene (a 2.2-kb RsaI fragment from position -410 to position +1761) was cloned by blunt-end ligation at the XhoI site of N2A in the reversed transcriptional orientation relative to the 5' LTR. A 255-bp fragment that includes the aLCR core element' was cloned at the BglII site of the 3' LTR by blunt-end ligation to generate the N2A-y retroviral construct (Fig 1) .
MATERIALS AND METHODS

Production
Three different packaging cell lines were used to generate retmviral stocks of the N2A-y retroviral vector. Two of these packaging cells produce amphotropic retroviruses (GP + envAM12I3 and PA317") and the third pmduces ecotropic retroviruses (GP + E86I5).
AU three packaging cell lines had been specifically designed to make production of replication-competent helper virus extremely unlikely.'6 These packaging cells were transfected with the N2A-y retroviral construct by electroporation as previously described.I7 Twenty-four hours after transfection, cells were split 15 and replated in the presence of G418 400 pg/mL (active concentration). Individual colonies were isolated 2 weeks later using cloning cylinders, and expanded into producer cell Li nes. Retroviral titers of supernatants from these producer cell lines were assayed by slot-blot hybridization as previously described.I8 Dilutions of two viral stocks of known titers (5 X l@ and 1 X to7 cFu/mL) were used as standards in the slot-blot assay. Titers of stocks from the highest-producer cell lines were confirmed by the widely used NM 3T3 assay of transfer of G418 mistauce as previously descri bed. "'
We have used a stringent vector rescue assay to test for the presence of replication-competent helper virus in the retroviral stocks. NJH 3T3 cells were infected with retroviral stocks and passaged for 1 month in the absence of G418 as previously de~cribed.'~.'~ Culture supernatants were harvested 1 month later and tested for the presence of retrovirus that can infect NIH 3T3 cells and transform them to G418-resistant cells.
Stability of retroviral sequences in tramfected and infected cells. DNA was isolated from all producer cell lines for analysis of stability of the integrated plasmid DNA by Southern bloaing. Ten micrograms of DNA were digested with Sa& separated on a 1% agarose gel, transferred to modified nylon membranes, and hybridized to a 255-bp aLCR probe. NJH 3T3 cells were infected with retroviruses as previously described? Individual NM 3T3 colonies that became G418-resistant after retroviral infection were expanded and their DNA was isolated for analysis of stability of the integrated retmviral DNA by Southern blotting. Ten micrograms of DNA from each clone were digested with X h I , transferred to modified nylon membranes, and hybridized to the 255-bp aLCR probe? &pression ofthe y-globin gene in tmnsduced MEL celLs. Two pools of infected MEL cells were generated by multivation with 2519 producer cell lines and selection in G418 media.' Five individual clones were isolated from one of these pools by limiting dilution. The nature of the retroviral integration event in each clone was analyzed by Southern analysis using the restriction enzyme XbaI, which generates unique junctional fragments. Pools and clones were expanded and induced to differentiate by exposure to dimethyl sulfoxide (DMSO) as previously described." Expression of endogenous mouse /3"J-globin genes and transduced human y-globin genes in these cells was assayed by S1 mapping as previously de~cribed.'~ In vitro transduction of primary murine hematopoietic progenitors. Murine bone marrow cells were obtained from femurs of adult BALBK mice.m*2' Bone marrow cells (5 X I d ) were resuspended in 1 mL of retmviral stocks supplemented with 5 ,ug/mL Polybrene and incubated overnight at 37°C in a humidified 5% COz incubator. The bone marrow cells were washed the next day and plated in 0.8% methylcellulose supplemented with 1% bovine serum albumin, 30% fetal calf serum, 0.1 mmol/L 2-mercaptoethanol, 2 moVL L-glutamine, 2% spleen cell-conditioned medium, and l U/mL recombinant murine erythropoietin qt a f i d cell concentration of 3 X 1041 m L . z y 3 Half the cells were plated in the presence of G418, and the other half were plated without it. Colonies that formed under both conditions were counted on day 12. Efficiency of retmviral transduction was assessed by comparing the number of colonies that formed in the presence and absence of G418.
RESULTS
A schematic map of the retroviral constructs is shown in Fig 1. The human Ayglobin gene was cloned in the reversed transcriptional orientation relative to the 5' LTR, and the aLCR core element was cloned in the 3' LTR. When the N2A-y retroviral vector integrates in the genome of an infected cell, the 3' LTR (including the aLCR) will be duplicated to flank the y-globin gene from both sides." We speculated that such an organization may have two advantages. First, expression of the y-globin gene would be enhanced by two copies of the aLCR instead of one. Although there is no clear evidence that two copies of the aLCR will give rise to an additive enhancement of expression of a linked gene, we believed that it was at least theoretically possible that two copies may result in more enhancement than a single copy. Second, some LCR elements such as HS5 of the P E R are believed to insulate a linked gene from the effect of surrounding sequences." If the aLCR turns out to have similar insulator activity, then flanking the y-globin gene with aLCR sequences from both sides may minimize effects of the sites of integration on the activity of the y-globin gene. between retroviral titers measured by slot-blot assay and by assay of NIH 3T3 transfer of G41 8 resistance. For example, the highest titer was determined to be 7 X IOh CFU/mL by slot-blot hybridization and 6 X IO6 CFU/mL by the G41 8 resistance assay. This suggests that cloning of the cvLCR and the y-globin gene in the retroviral genome does not result in a high proportion of noninfectious virions. The high-titer retroviral stock (6 to 7 X IO6 CFUlmL) that was derived from the amphotropic GP + envAM I2 producer cell line was used exclusively in the retroviral transduction experiments described in this report. No replication-competent helper viruses were detected in this retroviral stock by a stringent vector rescue assay.'"''
The stability of integration of the retroviral constructs in producer cell lines was investigated by Southem blotting. Figure 2 shows a representative autoradiograph from a Southern hybridization experiment in which DNAs from GP + envAM12-generated producer cell lines were probed with the aLCR fragment. In nine of 12 cell lines, the expected 4.3-kb San fragment was seen, whereas no hybridizing fragments were seen in the remaining three cell lines. This suggests that rearrangements of the integrated sequences in these three cell lines resulted in deletion of the aLCR element.
Stable integration was seen in 75% of GP + envAM 12-derived producer cell lines, 90% of PA3 17-derived producer cell lines, and 70% of GP + E86-derived producer cell lines.
We also assessed stability of the integration of retroviral sequences in transduced NIH 3T3 cells. DNA was harvested from clonal isolates of infected cells and analyzed by Southem blotting using XbaI, an enzyme with recognition sites in the 5' and 3' LTRs (Fig l) . When genomic DNA of a transduced cell is digested with XbaI and probed with an aLCR probe, two hybridizing fragments are expected: a constant 2.2-kb fragment, and a variable fragment that represents junctional sequences at the sites of chromosomal integration. Figure 3 shows a representative autoradiograph of a Southern blotting experiment in which six of eight clones show the expected constant fragment and different-sized variable fragments. Although the variable fragments in lanes 4 and 6 appear the same, the corresponding clones could not have resulted from the same integration event, since they were derived from different transduction experiments. Therefore, 75% of these unique clones show unrearranged integration of the viral genome, while 25% show sequence rearrangements.
We generated two different pools of transduced MEL cells and isolated five different clonal cell lines. All pools and cell lines were expanded and induced to differentiate by exposure to DMSO. RNA was isolated from uninduced and DMSO-induced cells and analyzed for mouse and human globin gene expression by quantitative SI mapping. A 5' end-labeled probe that detects human y-globin mRNA and 1 2 3 4 5 6 7 8 For personal use only. on October 3, 2017. by guest www.bloodjournal.org From a 3' end-labeled probe that detects mouse pmaJ mRNA were mixed together to assay mouse and human globin mRNA simultaneously in the same S 1 nuclease reactions. Figure 4A shows the results of analysis of globin gene expression in a pool of MEL cells infected with the amphotropic N2A-y retroviral vector. The success of DMSO induction is verified by the marked increase in mouse p""' mRNA in induced cells compared with uninduced cells. The transduced human y-globin genes were also expressed at a high level and in an inducible manner in this pool of infected cells. After correction for differences in specific activities of mouse and human y-globin probes, the level of expression of human y-globin gene was found to be equivalent to that of a single mouse P""'J-globin gene in transduced MEL cells. Five unique clones of transduced MEL cells were selected by limiting dilution from one of the expanded pools. As expected, each clone showed integration of a single copy of the retroviral genome (data not shown). Figure 4B shows results of an S1 nuclease assay that measures human yglobin expression in these five unique clones of transduced MEL cells. High-level inducible expression of human yglobin genes was seen in all five clones analyzed. Table 2 provides a comparison of the levels of expression of transduced human y-globin gene and endogenous mouse P,,,-globin gene in the different MEL clones. In induced MEL cells, the level of y-globin gene expression ranged from 75% to 1 10% of mouse Ti-globin gene expression. Interestingly, there was much more variability in y-globin gene expression in uninduced MEL cells, which ranged from 14.3% to I , 100% of mouse fl""'-globin gene expression. We also assessed the ability of N2A-y retroviruses to transduce primary murine CFUs in vitro. We compared the efficiency of transduction by the amphotropic N2A-y retrovirus (6 to 7 X IOh CFU/mL) versus the ecotropic N2 retrovirusI2 (1 X IO' CFU/mL) in two separate experiments. Results summarized in Table 3 suggest that the N2A-y retrovirus can transduce bone marrow progenitors as efficiently as its parental N2 retrovirus.
DISCUSSION
The retroviral vectors described in this report offer several advantages over previous generations of globin retroviral 25 When the P-globin gene was cloned in the reversed transcriptional orientation, it was possible to generate producer cell lines with unrearranged viral sequences, but titers of viral stocks from these producer cells were generally less than IO5 CFU/mL.2s Interestingly, when a human Pglobin minigene that lacks the two intervening sequences was used to generate the retroviral vectors, the retroviruses were stable and could be produced at titers greater than IO' CFU/mL." However, the P-globin minigene was completely inactive in transduced erythroid cell^.^.^^ These studies suggested that the intervening sequences that are indispensable for &globin expression may be responsible for genetic instability in retroviruses that carry an intact P-globin gene."" This was confirmed by a more recent study in which deletion of some IVS-I1 sequences of the human P-globin gene allowed production of more stable retroviruses at reasonably high titers of 4 X 10' CFU/mL. Although the level of expression of transduced P-globin genes was high in transduced cells, significant variability resulted from position-of-integration effects. The level of expression of human /?-globin gene per transduced copy ranged from 54% to 108% relative to the mouse P""J-globin gene."
Another factor that adversely affects the stability of globin vectors is the presence of one or more hypersensitive sites of the PLCR in the retroviral construct^.^^^ Unfortunately, it has not yet been possible to localize sequences within the PLCR that are responsible for this instability. When a 36-bp core sequence of HS2 was included in a P-globin retroviral vector, the overall stability appeared similar to that of vectors that contain the @-globin gene without PLCR sequences6 However, the activity of this truncated regulatory element was limited to twofold enhancement.' More studies are needed to determine whether it would be possible to remove the recombinogenic sequences of the PLCR without sacrificing its enhancer activity.
We have made two modifications in the design of our globin retroviral vectors that resulted in a significant improvement in their genetic stability. The first is the use of a fetal y-globin gene instead of an adult P-globin gene. We elected to use the fetal globin gene because y-globin chains are known to be more effective inhibitors of sickling than &globin chain^.^' Thus, a retrovirus that produces high levels of y-globin chains should be more effective in gene therapy for sickle cell disease than a retrovirus that produces P-globin chains. A high level of expression of y-globin chains should also be useful in gene therapy for P-thalassemia, since individuals that are homozygous for the deletion type of hereditary persistence of fetal hemoglobin are completely asymptomatic as a result of the compensatory increase in the production of y-globin chains.zx We hoped that the y-globin gene would be more stable in retroviruses than the P-globin gene, since the intervening sequences of the two genes are completely divergent.'"-"' Although the yglobin gene has not been previously used in retroviral vectors, its use in adeno-associated viruses did not appear to result in genetic instability of the vector sequences."
The second modification that we introduced in the design of N2A-y retroviral vectors is the use of aLCR instead of PLCR to enhance expression of the y-globin gene. In previous experiments from our laboratory that involved construction of plasmids that carry PLCR elements," we noted a high frequency of plasmid sequence rearrangements in the DH5a (recAl) bacterial strain and a much lower frequency of rearrangements in the recombination-minus (recA) background of the HBlOl strain (S. Ren and G.F. Atweh, unpublished observations, August 1992). We did not observe an increased frequency of sequence rearrangements when we performed similar cloning experiments to generate recombinant plasmids that carry the aLCR.' Even though the molecular basis of the genetic instability of PLCR sequences is still not known, we speculated that the same mechanism(s) of genetic instability in bacteria may also contribute to genetic instability in retroviral vectors. Based on this speculation, we predicted that use of the aLCR will not compromise genetic stability of retroviral vectors that carry the human y-globin gene. This prediction was borne out by production of the stable high-titer stocks of the N2A-y retrovirus that are described in this report. Although we were very pleased with these results, we would like to caution that these observations do not prove that the mechanisms of genetic instability of the PLCR in bacteria are the same as those in eukaryotic cells.
A second advantage of our retroviral globin vectors is the high-level expression of the transduced y-globin gene in erythroid cells. The level of expression of transduced yglobin gene was found to be equivalent to that of a single copy of the endogenous mouse PmaJ-globin gene in a pool of infected MEL cells. When expression was analyzed in five clonal isolates of transduced MEL cells, y-globin expression was observed to vary significantly in the uninduced state. Interestingly, when MEL cells were induced with DMSO, the level of expression of human y-globin gene became more uniform in the different clonal isolates. Previous studies had shown limited activity of the aLCR in uninduced MEL cells, which increased markedly with induction." We propose that the variability in expression of the y-globin gene in uninduced MEL cells may be a result of chromosomal position of integration effects that are neutralized when MEL cells are induced and the aLCR is activated. The experiments described in this report do not allow US to conclude whether the two copies of the aLCR are necessary for insulating the y-globin gene from the effects of surrounding sequences. Future studies should analyze the effects of position of integration on globin gene expression in retroviruses that integrate a single copy instead of two copies of the aLCR.
We have also demonstrated that the N2A-y retrovirus can infect primary murine hematopoietic progenitors by in vitro methylcellulose assays. It should be emphasized that the N2A-y versus a prototypic near-containing retrovirus (N2) under simple transduction conditions. We found that the efficiency of transduction of primary hematopoietic progenitors by the N2A-y retrovirus was similar to the efficiency of transduction by the parental N2 retrovirus. Since neor retroviral vectors have served as gold standards for bone marrow transduction experiments, the presence of the y-globin gene and the aLCR in N2A-y does not appear to compromise retroviral stability, titers, or ability to transduce primary hematopoietic cells. These promising results need to be extended to longterm bone marrow reconstitution experiments in which viral transductions are performed under optimized conditions. These studies may also allow us to determine the relevance of the lack of copy-number dependence in transgenic mice to the enhancement of the transduced y-globin gene by the aLCR in erythroid cells in vivo.
We hope that this new generation of globin retroviral vectors will allow us to move one step closer to effective gene therapy for sickle cell disease and &thalassemia.
